SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

64 hedge funds and large institutions have $40.7M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 17 closing their positions.

Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
11
Increased
11
Reduced
15
Closed
17
Calls
$281K
Puts
$2.73M
Net Calls
-$2.45M
Net Calls Change
-$2.58M

Top Buyers

1
SL
1
Siren LLC
Connecticut
$5.56M
2
BOCH
2
Blue Owl Capital Holdings
New York
$1.11M
3
EAM
3
Exome Asset Management
New York
$642K
4
UOC
4
UBS O'Connor
Illinois
$773K
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$167K

Top Sellers

1
AG
1
Artal Group
Luxembourg
$0
2
KCM
2
Kennedy Capital Management
Missouri
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
APM
4
Avidity Partners Management
Texas
$2.29M
5
DCM
5
DAFNA Capital Management
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$5.91M 2,750,151 +343 +0%
SL
2
Siren LLC
Connecticut
$5.56M 2,587,372 +2,587,372 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$4.45M 2,071,914 – –
SB
4
Samsara BioCapital
California
$3.84M 1,786,427 – –
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$3.16M 1,471,771 – –
FP
6
Flagship Pioneering
Massachusetts
$2.78M 1,293,849 – –
APM
7
Avidity Partners Management
Texas
$2.29M 1,063,000 -610,538 -36%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.05M 953,313 -14,904 -2%
DTC
9
Deep Track Capital
Connecticut
$1.78M 828,485 – –
OM
10
Opaleye Management
Massachusetts
$1.41M 654,943 -210,500 -24%
BOCH
11
Blue Owl Capital Holdings
New York
$1.11M 515,855 +175,000 +51%
UOC
12
UBS O'Connor
Illinois
$773K 359,305 +81,202 +29%
ECM
13
ExodusPoint Capital Management
New York
$673K 313,004 +49,313 +19%
EAM
14
Exome Asset Management
New York
$642K 298,575 +139,400 +88%
BlackRock
15
BlackRock
New York
$562K 261,579 +2,390 +0.9%
OFM
16
Omega Fund Management
Massachusetts
$540K 251,270 – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$440K 204,695 -21,415 -9%
Marshall Wace
18
Marshall Wace
United Kingdom
$345K 160,390 – –
PA
19
Perceptive Advisors
New York
$251K 116,754 – –
Renaissance Technologies
20
Renaissance Technologies
New York
$207K 96,435 -21,000 -18%
PCM
21
Prelude Capital Management
New York
$192K 89,097 +48,800 +121%
Walleye Capital
22
Walleye Capital
New York
$186K 86,641 -199,162 -70%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$167K 77,716 +49,557 +176%
State Street
24
State Street
Massachusetts
$149K 69,430 – –
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$113K 52,866 +18,288 +53%
1
2 3 4